To include your compound in the COVID-19 Resource Center, submit it here.

ALD-401: Phase II started

Aldagen began a double-blind, sham-controlled, U.S. Phase II trial

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE